1
|
Romanowska M, Stefanska I, Donevski S and
Brydak LB: Infections with A(H1N1)2009 influenza virus in Poland
during the last pandemic: experience of the National Influenza
Center. Adv Exp Med Biol. 756:271–283. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wan QF, Wang H, Lin Y, et al: Effects of
quercetin on CDK4 mRNA and protein expression in A549 cells
infected by H1N1. Biomed Rep. 1:766–770. 2013.PubMed/NCBI
|
3
|
Le QM, Kiso M, Someya K, et al: Avian flu:
isolation of drug-resistant H5N1 virus. Nature (London).
437:11082005. View
Article : Google Scholar : PubMed/NCBI
|
4
|
Saito R, Li D, Suzuki H, et al: High
prevalence of amantadine-resistance influenza a (H3N2) in six
prefectures, Japan, in the 2005–2006 season. J Med Virol.
79:1569–1576. 2007.PubMed/NCBI
|
5
|
Sharma U, Bala M, Saini R, et al:
Polysaccharide enriched immunomodulatory fractions from
Tinospora cordifolia(Willd) miers ax hook. f. & Thoms.
Indian J Exp Biol. 50:612–617. 2012.PubMed/NCBI
|
6
|
Evers DL, Chao CF, Wang X, et al: Human
cytomegalovirus-inhibitory flavonoids: studies on antiviral
activity and mechanism of action. Antiviral Res. 68:124–134. 2005.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Wan QF, Gu LG, Yin SJ, et al: Protection
effect of baicalin on lung injury of mice infected with influenza
FM1. Chin J Tradit Chin Med Pharm. 2848–2851. 2011.
|
8
|
Wan QF, Gu LG, Yin SJ, et al: Effect of
baicalin on cell apoptosis FAS/FAS-L system of pneumonia mice lung
tissue infected with FM1. Chin Pharmacol Bull. 27:1555–1559.
2011.
|
9
|
Kitamura K, Honda M, Yoshizaki H, et al:
Baicalin, an inhibitor of HIV-1 production in vitro. Antiviral Res.
37:131–140. 1998. View Article : Google Scholar : PubMed/NCBI
|
10
|
Romero MR, Efferth T, Serrano MA, et al:
Effect of artemisinin/artesunate as inhibitors of hepatitis B virus
production in an ‘in vitro’ replicative system. Antiviral Res.
68:75–83. 2005.PubMed/NCBI
|
11
|
Chu ZY, Chu M and Teng Y: Effect of
baicalin on in vivo anti-virus. Zhongguo Zhong Yao Za Zhi.
32:2413–2415. 2007.(In Chinese).
|
12
|
Xu G, Dou J, Zhang L, et al: Inhibitory
effects of baicalein on the influenza virus in vivo is determined
by baicalin in the serum. Biol Pharm Bull. 33:238–243. 2010.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Cook DN, Beck MA, Coffman TM, et al:
Requirement of MIP-1α for an inflammatory response to viral
infection. Science. 269:1583–1585. 1995.
|
15
|
Kawai T and Akira S: Toll-like receptor
and RIG-I-like receptor signaling. Ann NY Acad Sci. 1143:1–20.
2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
MacLeod H and Wetzler LM: T cell
activation by TLRs: A role for TLRs in the adaptive immune
response. Sci STKE. 2007:pe482007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Walsh KB, Teijaro JR, Zuniga EI, et al:
Toll-like receptor 7 is required for effective adaptive immune
responses that prevent persistent virus infection. Cell Host
Microbe. 11:643–653. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Rahman I, Gilmour PS, Jimenez LA, et al:
Oxidative stress and TNF-α induce histone acetylation and
NF-κB/AP-1 activation in alveolar epithelial cells: potential
mechanism in gene transcription in lung inflammation. Mol Cell
Biochem. 234–235:239–248. 2002.
|
19
|
Ludwig S, Ehrhardt C, Neumeier ER, et al:
Influenza virus-induced AP-1-dependent gene expression requires
activation of the JNK signaling pathway. J Biol Chem.
276:10990–10998. 2001. View Article : Google Scholar
|
20
|
Adachi M, Matsukura S, Tokunaga H, et al:
Expression of cytokines on human bronchial epithelial cells induced
by influenza virus A. Int Arch Allergy Immunol. 113:307–311. 1997.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Qian C and Cao X: Regulation of toll-like
receptor signaling pathways in innate immune responses. Ann NY Acad
Sci. 1283:67–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Aldridge JR Jr, Moselev CE, Boltz DA, et
al: TNF/iNOS-producing dendritic cells are the necessary evil of
lethal influenza virus infection. Proc Natl Acad Sci USA.
106:5306–5311. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Severa M and Fitzgerald KA: TLR-mediated
activation of type I IFN during antiviral immune responses:
fighting the battle to win the war. Curr Top Microbiol Immunol.
316:167–192. 2007.PubMed/NCBI
|
24
|
Tenoever BR, Ng SL, Chua MA, et al:
Multiple functions of the IKK-related kinase IKKɛ in
interferon-mediated antiviral immunity. Science. 315:1274–1278.
2007.PubMed/NCBI
|
25
|
Nimmerjahn F, Dudziak D, Dirmeier U, et
al: Active NF-κB signaling is a prerequisite for influenza virus
infection. J Gen Virol. 85:2347–2356. 2004.
|
26
|
Kumar N, Xin ZT, Liang Y, et al: NF-κB
signaling differentially regulates influenza virus RNA synthesis. J
Virol. 82:9880–9889. 2008.
|